STAT
JANUARY 26, 2024
When I enter, “what is pediatrics?” into an image search engine, I get back dozens of stock photos with smiling physicians listening to beaming children’s hearts or looking in their ears. I love those images. They reflect the routine joy and trust that encompass many days in the life of a pediatrician. Increasingly, though, the answer to that question doesn’t quite match the happy imagery.
ALiEM - Pharm Pearls
JANUARY 26, 2024
An 88-year-old female presented to the ER with a chief complaint of cough, vague abdominal pain, and a rash. The patient stated that she was started on Cipro eyedrops 1 or 2 days prior to presentation for a possible eye infection. A day prior to presentation she developed a purple purpuric rash on her lower extremities that gradually progressed up her legs, and was present on her buttocks thighs, and lower legs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JANUARY 26, 2024
There are more openly LGBTQ+ people in the U.S. than ever, but little is known about the unique health challenges they may face. That’s why some researchers are urging health systems to build the acronym SOGIE — for patients’ sexual orientation and gender identity and expression — into their data collection. In a paper published Wednesday in JAMA Cardiology , a group of cardiologists write that there is an urgent need to begin collecting SOGIE data more systematically
PharmaVoice
JANUARY 26, 2024
Amylyx Pharmaceuticals’ co-founders and co-CEOs Josh Cohen and Justin Klee explain their approach to dual leadership and why it can be a good fit in life sciences.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
JANUARY 26, 2024
WASHINGTON — Merck CEO Robert Davis and Johnson & Johnson CEO Joaquin Duato have agreed to voluntarily testify before the Senate health committee, avoiding a threatened subpoena, the committee announced Friday. The decision by the executives came after a public pressure campaign by Sanders to get the two executives and Bristol Myers Squibb CEO Chris Boerner to testify about why prices for their drugs are higher in the United States than in other countries.
Pharmaceutical Commerce
JANUARY 26, 2024
Concerns regarding hypoglycemia potentially linked to a counterfeit version of Ozempic come at a time in which reports have grown regarding the improper use of GLP-1 receptor agonists for the purpose of cosmetic weight loss.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
BioPharma Dive
JANUARY 26, 2024
The opinion would allow Abecma to be prescribed after two standard therapies and is the latest sign of CAR-T’s growing use in earlier cancer treatment.
STAT
JANUARY 26, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here with a look at a biotech rarity, a milestone on Wall Street, and pharma’s latest run-in with Washington.
The Pharmacist
JANUARY 26, 2024
The ‘success and full benefit’ of Pharmacy First will be reliant on the ‘building and sustaining of local relationships’ between general practice and community pharmacy teams, NHS England (NHSE) has said as the service is confirmed to launch next week. In a letter to primary care stakeholders published yesterday, NHSE said that Pharmacy First would […] The post Pharmacy First success relies on pharmacy and general practice ‘relationships’ appeared first on The Pharmacist.
STAT
JANUARY 26, 2024
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmaceutical Commerce
JANUARY 26, 2024
A non-randomized control trial investigates whether older adults with multiple chronic conditions can benefit by receiving more specialized services.
STAT
JANUARY 26, 2024
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up. We do, however, plan to catch up on our reading, promenade with the official mascots, and hold another listening party with Mrs. Pharmalot. For now, the rotation will likely include this , this , this and this.
Pharma Times
JANUARY 26, 2024
In 2022, over 39,000 people in England died prematurely of cardiovascular conditions
Pharmaceutical Technology
JANUARY 26, 2024
CAR-T cell therapies can provide durable cancer remission, however, a recent FDA investigation into reports of secondary T-cell malignancies has increased scrutiny of their risk profiles.
pharmaphorum
JANUARY 26, 2024
AbbVie has broken ground on a new $223 million expansion of its biologics manufacturing facility in Singapore, creating around 100 new jobs
European Pharmaceutical Review
JANUARY 26, 2024
The US Food and Drug Administration (FDA) has approved Dupixent ® (dupilumab) as a treatment for children patients aged one to 11 years, weighing at least 15kg with eosinophilic esophagitis (EoE). This new authorisation by the FDA’s expands its initial approval for EoE in May 2022 for patients aged 12 years and older, weighing at least 40kg. “With this approval, Dupixent becomes the first and only treatment option for EoE patients aged one year and older, weighing at least 15kg” “With this
pharmaphorum
JANUARY 26, 2024
Eli Lilly is weeks away from launching Mounjaro in the UK, after getting approval from the MHRA for a multi-dose injector version for diabetes and obesity
European Pharmaceutical Review
JANUARY 26, 2024
A paper, published in Nature Chemical Biology has reported the first ‘free-from ‘tree’ production of a key vaccine ingredient sourced from the soapbark tree. Researchers from the John Innes Centre, a research institute in the UK, have reconstituted the chemical pathway of the potent adjuvant molecule QS-21 in a tobacco plant. Bioengineering vaccine adjuvants The paper explained: “QS-21 is a potent vaccine adjuvant currently sourced by extraction from the Chilean soapbark tree.
Pharma Times
JANUARY 26, 2024
HPV is a common group of viruses which can sometimes lead to cancer
pharmaphorum
JANUARY 26, 2024
Report on UK biotech sector by Tony Blair and William Hague calls for an NHS trust to be set up to oversee and sell patient data
The Guardian - Pharmaceutical Industry
JANUARY 26, 2024
Frontline staff are having to make compromises to treat patients appropriately. It’s scandalous nothing is being done Medicine shortages in the UK have been a regular feature on newspaper front pages in recent years. As a doctor on the frontline, I see how this instability in our medicine supply chain is playing out on the ground. I work in a large city hospital and am used to meeting disgruntled patients who have had to wait hours in clinic to receive treatment.
pharmaphorum
JANUARY 26, 2024
ArriVent BioPharma completes the second biotech IPO of 2024, raising $175m that will help advance its late-stage lung cancer drug furmonertinib
World Pharma News
JANUARY 26, 2024
A protein in the immune system can be manipulated to help overcome bowel cancer, according to new research from The Australian National University (ANU). Bowel cancer claims more than 100 lives in Australia each week, yet around 90 per cent of cases can be successfully treated if detected early.
Big Molecule Watch
JANUARY 26, 2024
On January 17, 2024, Celltrion announced the U.S. launch of a new, 80 mg/0.8 ml dosage strength of its HUMIRA® biosimilar, YUFLYMA® (adalimumab-aaty). As we previously reported , Celltrion received FDA approval for an 80 mg/0.8 ml dose and a 20 mg/0.2 ml dose on October 4, 2023. Celltrion’s January 2024 announcement indicates that it expects the 20 mg version of YUFLYMA® “to be available in pharmacies in late Q1 2024.
Pharmafile
JANUARY 26, 2024
AbbVie has announced that it has invested $223m in an expansion to its Singapore manufacturing facility. This will create more than 100 new jobs and increase the company’s biologics manufacturing capacity. The facility is located in Singapore’s Tuas Biomedical Park and is a state-of-the-art small-molecule and biologics manufacturing site. The investment is intended to add […] The post AbbVie invests $223m in Singapore manufacturing site appeared first on Pharmafile.
BioPharma Dive
JANUARY 26, 2024
The EMA’s drugs committee again recommended rescinding an OK for Translarna, which was cleared in 2014 despite questions about its benefit.
Pharmafile
JANUARY 26, 2024
The Medicines and Healthcare products Regulatory Agency (MHRA) has announced that it has approved a four-dose version of the diabetes and weight management medicine Mounjara (tirzepatide) in the form of Mounjaro KwikPen. The four-dose version is intended to cover a month’s treatment and is approved to treat adult patients with type 2 diabetes and for […] The post MHRA approves Mounjaro for diabetes and weight management appeared first on Pharmafile.
pharmaphorum
JANUARY 26, 2024
From pandemic spotlight to global progress: Navigating technology transfer for healthcare innovation Mike.
Pharmaceutical Technology
JANUARY 26, 2024
Atossa Therapeutics estimates a Q3 Phase II readout for Z-endoxifen, as it plans a Phase III preventative breast cancer trial.
Digital Pharmacist
JANUARY 26, 2024
In the fast-paced world of community pharmacy, providing an inviting and efficient front-end experience is crucial for customer satisfaction. A well-designed and refreshed pharmacy front end not only enhances the customer experience but also contributes to the overall success of your business. In this blog post, we will explore effective ways to refresh your pharmacy’s front end and create a positive environment for both customers and staff.
Pharmaceutical Commerce
JANUARY 26, 2024
As providers and healthcare professionals recognize the potential of long-acting injectables to fight the opioid epidemic, many are actively transitioning from oral options to injectables.
PharmExec
JANUARY 26, 2024
In an interview with PharmExec Associate Editor Don Tracy, Jingsong Wang discusses Nona Biosciences’ recent exclusive license agreement with Pfizer Inc. for the development and commercialization of HBM9033.
pharmaphorum
JANUARY 26, 2024
SAE Media Group's 11th Annual Pre-Filled Syringes East Coast Conference will return to Boston in April 2024 to bring you the latest advances in the combination product drug delivery space.
Pharmaceutical Technology
JANUARY 26, 2024
Type-2 diabetes patients continue to be impacted by GLP-1 RA drug shortages in the UK with an NHS alert issuing guidelines on drug substitutions.
Expert insights. Personalized for you.
321 
Let's personalize your content